Global Health per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹20.70₹20.71₹17.92₹17.80₹12.58
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹20.67₹20.66₹17.92₹17.80₹12.57
₹147.44₹147.44₹126.08₹108.21₹90.54
₹174.30₹164.14₹137.47₹121.97₹100.46
—₹26.59₹23.22₹22.80₹24.03
−₹4.61−₹4.61₹3.99₹12.42₹15.23
—₹0.50₹0.00₹0.00₹0.00
26.926.926.926.926.8
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MEDANTA₹1,299.70

Global Health Ltd.

· Pharma & Health
₹ CrorePeersMAXHEALTHAPOLLOHOSPFORTISGLAXOANTHEMAJANTPHARMIPCALABABBOTINDIAMcap ₹34,922 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS12.5817.8017.9220.7120.70
Diluted EPS12.5717.8017.9220.6620.67
Book Value per Share90.54108.21126.08147.44147.44
Revenue per Share100.46121.97137.47164.14174.30
Cash Flow per Share24.0322.8023.2226.59—
Free Cash Flow per Share15.2312.423.99-4.61-4.61
Dividends per Share0.000.000.000.50—
Shares Outstanding (cr)26.826.926.926.926.9
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.